UBS AM
RPTP

UBS AM’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

UBS AM’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-41,657
Closed -$374K – 2858
2016
Q3 		$374K Sell
41,657
-1,247,028
-97% -$8.87M ﹤0.01% 2148
2016
Q2 		$6.92M Buy
1,288,685
+20,650
+2% +$106K 0.01% 951
2016
Q1 		$5.83M Sell
1,268,035
-5,100
-0.4% -$20.5K 0.01% 983
2015
Q4 		$6.62M Buy
1,273,135
+3,300
+0.3% +$19.1K 0.01% 980
2015
Q3 		$7.68M Sell
1,269,835
-25,462
-2% -$312K 0.01% 932
2015
Q2 		$20.5M Buy
1,295,297
+305,100
+31% +$3.71M 0.02% 712
2015
Q1 		$10.8M Buy
990,197
+961,400
+3,339% +$9.81M 0.01% 863
2014
Q4 		$303K Buy
28,797
+3,300
+13% +$32.2K ﹤0.01% 2229
2014
Q3 		$245K Hold
25,497
– – ﹤0.01% 2262
2014
Q2 		$294K Hold
25,497
– – ﹤0.01% 2199
2014
Q1 		$255K Buy
25,497
+1,600
+7% +$23.1K ﹤0.01% 2284
2013
Q4 		$311K Sell
23,897
-600
-2% -$8.26K ﹤0.01% 2106
2013
Q3 		$366K Sell
24,497
-189,600
-89% -$2.27M ﹤0.01% 1959
2013
Q2 		$2M Buy
+214,097
New +$1.45M ﹤0.01% 1214

UBS AM's RPTP Position: Q4 2016 in Review

UBS AM sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 41,657 shares — an estimated $374K sold.

UBS AM first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $20.5M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • UBS AM reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • UBS AM sold 41,657 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $374K.
  • UBS AM first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
  • UBS AM's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $20.5M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on UBS AM's 13F filing for Q4 2016, filed 14 Feb 2017.